JEFFREY W. SHERMAN - Director at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
XERS on Nasdaq
All Insider Reports
All Insider Reports

JEFFREY W. SHERMAN - trading volume in the past year for Xeris Biopharma Holdings, Inc.

Holdings reported by JEFFREY W. SHERMAN for Xeris Biopharma Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 219,188 $1,736,166 $7.92 28 Aug 2025 Direct
Common Stock 5,400 $27,594 $5.11 28 Aug 2025 By: JEFFREY W SHERMAN LIVING TRUST U/A DTD 03/21/2001
Stock Option (Right to Buy) 0 28 Aug 2025 Direct Common Stock

Transactions reported by JEFFREY W. SHERMAN for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.